IsoRay Medical Overview

  • Founded
  • 2004

Founded
  • Status
  • Public

  • Employees
  • 67

Employees
  • Stock Symbol
  • ISR

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $0.37

  • (As of Friday Closing)

IsoRay Medical General Information

Description

Isoray Inc offers is a medical technology company. The company designs and develops personalized brachytherapy products that provide more cost-effective cancer treatment. It is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to the cancerous tumor. It derives most of its revenue from the United States of America.

Contact Information

Website
www.isoray.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
ASE
Primary Office
  • 350 Hills Street
  • Suite 106
  • Richland, WA 99354
  • United States
+1 (509) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IsoRay Medical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.37 $0.37 $0.25 - $0.75 $52.5M 142M 245K -$0.05

IsoRay Medical Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019
EV (8,141) 48,872 36,237 21,217
Revenue 11,000 10,053 9,680 7,314
EBITDA (6,150) (3,297) (3,329) (5,116)
Net Income (6,255) (3,387) (3,446) (5,144)
Total Assets 66,113 70,416 8,699 9,422
Total Debt 588 776 1,005 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IsoRay Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IsoRay Medical‘s full profile, request access.

Request a free trial

IsoRay Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Isoray Inc offers is a medical technology company. The company designs and develops personalized brachytherapy products
Drug Discovery
Richland, WA
67 As of 2021
000.00
00000000 000.00

00000

la pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt moll
0000 000000000
Janesville, WI
000 As of 0000
00.000
0000000 0000 00.000

0000 0

t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse ci
0000 000000000
Cambridge, MA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IsoRay Medical Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SHINE Medical Technologies Private Equity-Backed Janesville, WI 000 00.000 0000000 0000 00.000
0000 00000000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
000000000 0000000 Venture Capital-Backed Hayward, CA 000 00000 000000000 00 00000
0-0000 Venture Capital-Backed Shilat, Israel 00 0000 0000000000 0 0000
You’re viewing 5 of 18 competitors. Get the full list »

IsoRay Medical Patents

IsoRay Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210353960-A1 Device for shielding implantable radioactive sources to achieve directional dosing Pending 13-May-2020 0000000000
US-11298846-B1 Cutting device for brachytherapy seed implantation sleeves Active 02-Nov-2017 00000000 0
EP-3703804-A4 Device for loading brachytherapy seeds into implantation sleeves Granted 02-Nov-2017 0000000000 0
EP-3703804-A1 Device for loading brachytherapy seeds into implantation sleeves Granted 02-Nov-2017 0000000000
US-10328278-B2 Device for loading brachytherapy seeds into implantation sleeves Active 02-Nov-2017 A61N5/1007 00
To view IsoRay Medical’s complete patent history, request access »

IsoRay Medical Executive Team (11)

Name Title Board Seat Contact Info
Lori Woods Chief Executive Officer & Board Member
Jonathan Hunt Chief Financial Officer, Finance
Jennifer Streeter Chief Operating Officer, Operations & Vice President
Mark Austin Chief Accounting Officer, Accounting & Controller, Finance
William Cavanagh III Executive
You’re viewing 5 of 11 executive team members. Get the full list »

IsoRay Medical Board Members (6)

Name Representing Role Since
Alan Hoffmann IsoRay Medical Board Member 000 0000
Lori Woods IsoRay Medical Chief Executive Officer & Board Member 000 0000
Michael Mccormick Self Chairman & Board Member 000 0000
Philip Vitale MD IsoRay Medical Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

IsoRay Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IsoRay Medical Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 23-Jan-2008 000000000 Drug Delivery 00000 000
Century Park Pictures 28-Jul-2005 Merger/Acquisition Holding Companies 00000 000
To view IsoRay Medical’s complete investments and acquisitions history, request access »